Fig. 4From: Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitisTEWL measurements for the treatment and control groups. At 0, 4 and 8 weeks of treatment, TEWL was measured from the pinnae (a), axilla (b) and inguinal area (c) in all AD dogs. Data reported as mean ± SEM (n = 6 vs 6)Back to article page